Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ZTS Insider Trading

Zoetis Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Zoetis Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2018-06-07 03:17 2016-10-14 Sanjay Khosla Director BUY $64.57 17 $1,098 17 +100.0%
2018-06-07 03:17 2018-06-04 Sanjay Khosla Director SELL $85.33 17 $1,451 2,568 -0.7%
2018-05-04 00:21 2018-05-01 PECK KRISTIN C Officer - Executive Vice President SELL $83.46 4,877 $407,034 42,652 -10.3%
2018-03-19 23:49 2018-03-16 Chen Heidi C. Officer - Executive Vice President SELL $84.71 7,383 $625,414 20,162 -26.8%
2018-03-12 23:53 2018-03-09 Trawicki Roman Officer - Executive Vice President OPT+S $83.10 8,568 $712,001 2,889 0.0%
2018-03-02 01:07 2018-02-27 Bernal Alejandro Officer - Executive Vice President OPT+S $83.01 15,709 $1,304,004 6,310 0.0%
2018-02-27 00:32 2018-02-23 Knupp Catherine A. Officer - Executive Vice President OPT+S $82.13 42,796 $3,514,835 24,415 0.0%
2018-02-24 00:46 2018-02-23 Trawicki Roman Officer - Executive Vice President OPT+S $82.00 23,885 $1,958,570 0 0.0%
2018-02-24 00:43 2018-02-21 Bernal Alejandro Officer - Executive Vice President OPT+S $81.16 69,640 $5,651,676 6,310 0.0%
2018-02-24 00:37 2018-02-21 Lagano Roxanne Officer - Executive Vice President OPT+S $81.02 35,663 $2,889,416 14,256 0.0%
2018-02-24 00:36 2018-02-21 PECK KRISTIN C Officer - Executive Vice President OPT+S $81.24 32,000 $2,599,680 35,530 0.0%
2018-02-22 01:02 2018-02-20 Trawicki Roman Officer - Executive Vice President SELL $80.32 3,804 $305,537 0 -100.0%
2018-02-22 00:58 2018-02-20 Chen Heidi C. Officer - Executive Vice President OPT+S $81.02 37,453 $3,034,442 20,162 0.0%
2017-05-16 00:11 2017-05-12 Knupp Catherine A. Officer - Executive Vice President SELL $60.16 5,785 $348,026 24,415 -19.2%
2016-11-24 00:29 2016-11-22 PECK KRISTIN C Officer - Executive Vice President SELL $49.55 10,092 $500,059 22,768 -30.7%
2016-11-10 02:17 2016-11-08 Lagano Roxanne Officer - Executive Vice President SELL $50.43 9,797 $494,063 8,063 -54.9%
2016-09-07 02:12 2016-09-06 MCCALLISTER MICHAEL B Director BUY $51.34 2,000 $102,680 9,000 +28.6%
2016-09-02 23:17 2016-09-02 Fenton Andrew Officer - Executive Vice President SELL $51.25 13,870 $710,838 189 -98.7%
2016-09-02 23:16 2016-09-01 Chen Heidi C. Officer - Executive Vice President OPT+S $50.98 32,097 $1,636,305 13,963 0.0%
2016-05-11 00:08 2016-05-09 Pershing Square Capital Management, L.P. Director SELL $46.55 16,850,000 $784,367,500 24,973,145 -40.3%
2015-07-03 00:05 2015-07-01 Pershing Square Capital Management, L.P. Director SELL $48.22 1,540,713 $74,293,181 41,823,145 -3.6%
2015-07-03 00:05 2015-07-01 Pershing Square Capital Management, L.P. Director BUY $48.22 1,540,713 $74,293,181 41,823,145 +3.8%
2013-08-12 23:00 2013-08-08 MCCALLISTER MICHAEL B Director BUY $31.35 7,000 $219,461 7,000 +100.0%
2013-02-09 00:24 2013-02-06 STEERE WILLIAM C JR Director BUY $26.00 4,500 $117,000 4,500 +100.0%
2013-02-09 00:24 2013-02-06 Norden Gregory Director BUY $26.00 3,000 $78,000 3,000 +100.0%
2013-02-09 00:23 2013-02-06 SCHULMAN AMY W Director BUY $26.00 5,000 $130,000 5,000 +100.0%
2013-02-09 00:23 2013-02-06 HILL CHARLES H Director BUY $26.00 5,000 $130,000 5,000 +100.0%
2013-02-09 00:22 2013-02-06 Giordano Douglas E. Director BUY $26.00 5,000 $130,000 5,000 +100.0%
2013-02-09 00:22 2013-02-06 Germano Geno J Director BUY $26.00 5,000 $130,000 5,000 +100.0%
2013-02-09 00:21 2013-02-06 DAMELIO FRANK A Director BUY $26.00 5,000 $130,000 5,000 +100.0%
2013-02-09 00:21 2013-02-06 Lewis Clinton A. Jr. Officer - Executive Vice President BUY $26.00 500 $13,000 500 +100.0%
2013-02-09 00:20 2013-02-06 Lee Joyce J. Officer - Executive Vice President BUY $26.00 2,000 $52,000 2,000 +100.0%
2013-02-09 00:20 2013-02-06 Lagano Roxanne Officer - Executive Vice President BUY $26.00 2,000 $52,000 2,000 +100.0%
2013-02-09 00:20 2013-02-06 Knupp Catherine A. Officer - Executive Vice President BUY $26.00 1,000 $26,000 1,000 +100.0%
2013-02-09 00:19 2013-02-06 PFIZER INC Director, 10% owner SELL $0.00 99,015,000 $0 0 -100.0%
2013-02-09 00:19 2013-02-06 Chen Heidi C. Officer - Executive Vice President BUY $26.00 2,500 $65,000 2,500 +100.0%
2013-02-09 00:19 2013-02-06 Beaty Sandra J. Officer - Executive Vice President BUY $26.00 2,000 $52,000 2,000 +100.0%
2013-02-05 03:59 2013-02-01 Weiskopf Stefan Officer - Executive Vice President BUY $31.14 320 $9,965 320 +100.0%
SHOW ENTRIES
151-188 OF 188

How to Interpret $ZTS Trades

Not every insider transaction in Zoetis Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ZTS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ZTS

Insider activity data for Zoetis Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ZTS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.